Articolul precedent |
Articolul urmator |
159 0 |
Căutarea după subiecte similare conform CZU |
15+616.89-008.454-085.215+616.89-008.454-085.2 (1) |
PHILOSOPHY. PSYCHOLOGY (4512) |
Psychiatry. Pathological psychiatry. Psychopathology. Phrenopathies. Psychoses. Mental abnormality. Morbid mental states. Behavioural and emotional disturbances (286) |
SM ISO690:2012 SCUTARI, Corina, MAGALEAS, Serghei, ELENI, Vladimir. The role of the pharmacist in the medication of alcoholism. In: Direcții de reformare a sistemului farmaceutic din perspectiva cursului european al Republicii Moldova, Ed. Ediția a 2-a, 28 aprilie 2023, Chişinău. Comrat: Universitatea de Stat din Comrat, 2023, Ediția a 2-a, pp. 225-226. ISBN 978-5-88554-205-0. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Direcții de reformare a sistemului farmaceutic din perspectiva cursului european al Republicii Moldova Ediția a 2-a, 2023 |
|||||
Conferința "Direcții de reformare a sistemului farmaceutic din perspectiva cursului european al Republicii Moldova" Ediția a 2-a, Chişinău, Moldova, 28 aprilie 2023 | |||||
|
|||||
CZU: 15+616.89-008.454-085.215+616.89-008.454-085.2 | |||||
Pag. 225-226 | |||||
|
|||||
Descarcă PDF | |||||
Rezumat | |||||
Introduction. The Republic of Moldova is an ex-Soviet country, where the level of alcohol consumption is among the highest in the world [1]. The role that pharmacists can play in improving acces to evidence-based pharmacotherapy as well as in promoting medication education for patients with chronic alcoholism is currently being emphasized [2]. Aim of the study. To study the risk factors, clinical manifestations, consequences and up to date methods of treatment of alcoholism. Material and methods. A selection and analysis of bibliographic sources from the PubMed database and from specialized journals was carried out regarding risk factors, consequences and the pharmacist's role in the medication of alcoholism. Results. Alcohol dependence causes increased morbidity and mortality that are associated with neurological disorders (depressive episodes, severe anxiety, insomnia, suicide and abuse of other drugs), with high occurrence of cardiovascular diseases, cancers and liver cirrhosis. Current pharmacological and behavioral treatments can help patients reduce alcohol consumption or facilitate alcohol abstinence. They include three main components, such as withdrawal therapy, detoxification and abolition of abstinence through the use of drugs such as: disulfiram, naltrexone, acamprosate, etc. One of the most important tasks of doctors and pharmacists would be to convince the patient to stop drinking alcohol not only during hospitalization, but, as far as possible, in the long term, or to adopt the occasional consumption model (depending on the severity of the concomitant diseases caused by alcohol consumption or mental problems). Researches where pharmacists' attitudes towards alcohol-related problems were assessed, using brief questions on perception of alcohol-related problems before training and after the brief intervention, were examined. Pharmacists with a positive attitude towards alcohol users performed more alcohol interventions and had higher job satisfaction than pharmacists with less positive attitudes. Conclusions: The role of the pharmacist increases when taking the conception of improving the results of pharmacotherapy of patients with alcoholism. It improves the results by identifying and evaluating patients at high risk of alcohol abuse. |
|||||
Cuvinte-cheie alcoholism, medication, pharmacist |
|||||
|